Drug Targeting and Design

Drug Design is often remarked as rational drug design or just rational design, the inventive process of finding new medications supported the knowledge of a biological target. The drug is most ordinarily an organic small molecule that activates or inhibits the function of a biomolecule like a protein, which successively ends up in a therapeutic benefit to the patient. Drug design involves the planning of substances or the molecules which are complementary in shape and charge to the biomolecule target with which they interact and thus will bind to the targeted molecule. Within the most simple sense drug design habitually but not necessarily relies on computer modelling techniques. This sort of modelling is usually remarked as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecule target is thought as structure-based drug design. As well as to pharmaceutics, biopharmaceuticals and particularly therapeutic antibodies are an increasingly important class of medicine for the drug delivery system; computational methods for improving the selectivity, affinity and stability of this protein-based therapeutics have also been developed.

  • Track 5-1Drug targeting strategies
  • Track 5-2Factors influencing drug targeting
  • Track 5-3Advances in drug targeting components
  • Track 5-4Recent approaches to drug targeting
  • Track 5-5Computer aided drug design
  • Track5-6Rational drug design

 

Related Conference of Pharmaceutical Sciences